Status:
COMPLETED
Pleural Manometry in Thoracocentesis
Lead Sponsor:
Aly Sherif Hassaballa
Conditions:
Thoracocentesis of Pleural Effusion
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The study aiming to measure the pleural pressure during thoracocentesis in patients with pleural effusion and the value of their measurement in both diagnostic and therapeutic decisions.
Detailed Description
This prospective controlled trial study will be performed between July 2019 and December 2020. the investigators will enroll patients with large volume pleural effusion referred to our Cardiothoracic ...
Eligibility Criteria
Inclusion
- age between 18 and 85 years,
- pleural effusion occupying at least one-third of the ipsilateral hemithorax in P-A chest radiograph (CXR)
- no contraindications for therapeutic thoracentesis
- general health condition allowing prolonged procedure of therapeutic thoracentesis.
Exclusion
- patients with very small amounts of pleural effusion
- patients on mechanical ventilation
- patients using anticoagulant therapy
- patients refusing to be subjected to thoracocentesis.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04420663
Start Date
July 1 2019
End Date
December 31 2021
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiothoracic Surgery Hospital, Faculty of Medicine, Ain Shams University
Cairo, Egypt